what class of medication is tirzepatide New Blockbuster Type 2 Mounjaro Gets FDA Approval GLP-1 Medications for Weight Loss:

Most common adverse effects included nausea, diarrhea, constipation and vomiting

Those who used GLP-1 agonists had a 14% lower risk of developing cirrhosis, a 22% lower risk of cirrhosis complications (decompensation, liver cancer or liver transplant) and an 11% lower risk of death from any cause

Because of this, your clinician might suggest waiting before evaluating results, so the medication has time to reach its full effect

There tends to be more significant results becoming apparent within the first six months

Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice